Antibiotic-Induced Gut Microbiota Disruption Decreases TNF-α Release by Mononuclear Cells in Healthy Adults

Clinical and Translational Gastroenterology

Volumn 7, Issue 8, 2016, Pages

  Lankelma, Jacqueline M ^a   Belzer, Clara ^b   Hoogendijk, Arie J ^a   De Vos, Alex F ^a   De Vos, Willem M ^b,c   Van Der Poll, Tom ^a   Wiersinga, W Joost ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CELL SURFACE MARKER; CIPROFLOXACIN; DNA 16S; HLA DR ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; L SELECTIN; LIPOPOLYSACCHARIDE; METRONIDAZOLE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTEROIDES; BLOOD SAMPLING; BURKHOLDERIA PSEUDOMALLEI; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA SEQUENCE; EX VIVO STUDY; FECES ANALYSIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INNATE IMMUNITY; INTESTINE FLORA; KLEBSIELLA PNEUMONIAE; LACHNOSPIRACEAE; LACTOBACILLUS; LEUKOCYTE DIFFERENTIAL COUNT; MALE; MICROBIAL DIVERSITY; MONOCYTE; MONONUCLEAR CELL; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; PHAGOCYTOSIS; PREVOTELLA; PRIORITY JOURNAL; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; STREPTOCOCCUS; STREPTOPHYTA;

EID: 84982812938     PISSN: None     EISSN: 2155384X     Source Type: Journal    
DOI: 10.1038/ctg.2016.43     Document Type: Article

References (27)

1. Hicks LA, Bartoces MG, Roberts RM et al. US outpatient antibiotic prescribing variation according to geography, patient population, provider specialty in 2011. Clin Infect Dis 2015; 60: 1308-1316.
2. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 2011; 108 (Suppl 1): 4554-4561.
3. Kamada N, Nunez G. Regulation of the immune system by the resident intestinal bacteria. Gastroenterology 2014; 146: 1477-1488.
4. Schuijt TJ, van der Poll T, de Vos WM et al. The intestinal microbiota and host immune interactions in the critically ill. Trends Microbiol 2013; 21: 221-229.
5. Kassam Z, Lee CH, Yuan Y et al. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 2013; 108: 500-508.
6. Moayyedi P, Surette MG, Kim PT et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 2015; 149: 102-109 e6.
7. Clarke TB, Davis KM, Lysenko ES et al. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med 2010; 16: 228-231.
8. Deshmukh HS, Liu Y, Menkiti OR et al. The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice. Nat Med 2014; 20: 524-530.
9. Khosravi A, Yanez A, Price JG et al. Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe 2014; 15: 374-381.
10. Schuijt TJ, Lankelma JM, Scicluna BP et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut 2016; 65: 575-583.
11. Trompette A, Gollwitzer ES, Yadava K et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 2014; 20: 159-166.
12. Balmer ML, Schurch CM, Saito Y et al. Microbiota-derived compounds drive steady-state granulopoiesis via MyD88/TICAM signaling. J Immunol 2014; 193: 5273-5283.
13. Clarke TB. Early innate immunity to bacterial infection in the lung is regulated systemically by the commensal microbiota via nod-like receptor ligands. Infect Immun 2014; 82: 4596-4606.
14. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013; 13: 260-268.
15. van Vught LA, Wiewel MA, Hoogendijk AJ et al. Reduced responsiveness of blood leukocytes to lipopolysaccharide does not predict nosocomial infections in critically ill patients. Shock 2015; 44: 110-114.
16. deVos AF, Pater JM, van den Pangaart PS et al. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands. J Immunol 2009; 183: 533-542.
17. van den Bogert B, Erkus O, Boekhorst J et al. Diversity of human small intestinal Streptococcus and Veillonella populations. FEMS Microbiol Ecol 2013; 85: 376-388.
18. Salonen A, Nikkila J, Jalanka-Tuovinen J et al. Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis. J Microbiol Methods 2010; 81: 127-134.
19. Korpela K, Salonen A, Virta LJ et al. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat Commun 2016; 7: 10410.
20. Prescott HC, Dickson RP, Rogers MA et al. Hospitalization type and subsequent severe sepsis. Am J Respir Crit Care Med 2015; 192: 581-588.
21. Ojima M, Motooka D, Shimizu K et al. Metagenomic analysis reveals dynamic changes of whole gut microbiota in the acute phase of intensive care unit patients. Dig Dis Sci 2015.
22. Shimizu K, Ogura H, Hamasaki T et al. Altered gut flora are associated with septic complications and death in critically ill patients with systemic inflammatory response syndrome. Dig Dis Sci 2011; 56: 1171-1177.
23. Shimizu K, Ogura H, Tomono K et al. Patterns of Gram-stained fecal flora as a quick diagnostic marker in patients with severe SIRS. Dig Dis Sci 2011; 56: 1782-1788.
24. Zaborin A, Smith D, Garfield K et al. Membership and behavior of ultra-low-diversity pathogen communities present in the gut of humans during prolonged critical illness. MBio 2014; 5: e01361-14.
25. Human Microbiome Project ConsortiumStructure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207-214.
26. Bongartz T, Sutton AJ, Sweeting MJ et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006; 295: 2275-2285.
27. Li Q, Wang C, Tang C et al. Therapeutic modulation and reestablishment of the intestinal microbiota with fecal microbiota transplantation resolves sepsis and diarrhea in a patient. Am J Gastroenterol 2014; 109: 1832-1834.